Nicardipine Reduces Blood Pressure Variability After Spontaneous Intracerebral Hemorrhage
- 261 Downloads
Blood pressure variability (BPV) is an independent predictor for early hematoma expansion, neurologic deterioration, and mortality. There are no studies on the effect of intravenous (IV) antihypertensive drugs on BPV. We sought to determine whether patients have more BPV with certain antihypertensive agents, in particular the effect of IV nicardipine.
We conducted a single-center, retrospective chart review of individuals diagnosed with spontaneous intracerebral hemorrhage (ICH) receiving labetalol, hydralazine, and/or nicardipine within 24 h of hospital admission to assess the primary endpoint of BPV, defined as the standard deviation of systolic BP, with labetalol and/or hydralazine compared to nicardipine ± labetalol and/or hydralazine. Repeated measures linear regression was performed to compare BPV over 24 h between regimens, and Cox proportional hazards regression was used to compare the time to goal SBP between regimens.
Of the 1330 patients screened, 272 were included in our analysis; those included had a mean age of 69 years with 87.9% of Caucasian race. A total of 164 patients received IV bolus antihypertensives alone (labetalol, hydralazine or both), and 108 patients received IV nicardipine with or without additional IV boluses (labetalol, hydralazine, or both). Those who had IV nicardipine had significantly less BPV (p = 0.04) and was more likely to attain an SBP goal < 140 mmHg (p < 0.01).
Our study suggests patients with ICH who do not receive a nicardipine-based antihypertensive regimen have more BPV, which has been associated with poor clinical outcomes. Prospective, randomized, controlled trials are needed to determine the impact of specific antihypertensive regimens on clinical outcomes.
KeywordsIntracerebral hemorrhage Blood pressure variability Antihypertensive Nicardipine Labetalol Hydralazine Bolus Infusion
JOP designed and directed this study and drafted the manuscript; BMR, AAR, EFMW and PJ participated in the conceptual framing of the study, data analysis, and revision of the manuscript; RAD and KCM completed the statically analysis of the manuscript.
Source of support
This study was funded by a research grant from Mayo Clinic Pharmacy Services Discretionary Fund.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 6.Parati G, Ravogli A, Frattola A, et al. Blood pressure variability: clinical implications and effects of antihypertensive treatment. J Hypertens. 1994;12(5):S35–40.Google Scholar
- 18.Trandate (labetalol hydrochloride) injection [package insert]. San Diego, CA: Prometheus Laboratories Inc.; 2010.Google Scholar
- 19.Hydralazine hydrochloride injection [package insert]. Sirley, NY: American Regent, Inc.; 2013.Google Scholar
- 20.Cardene IV premixed injection (nicardipine) [package insert]. Deerfield, IL: Baxter Healthcare Corporation; 2010.Google Scholar
- 22.Manning LS, Mistri AK, Potter J, Rothwell PM, Robinson TG. Short-term blood pressure variability in acute stroke: post hoc analysis of the controlling hypertension and hypotension immediately post stroke and continue or stop post-stroke antihypertensives collaborative study trials. Stroke. 2015;46:1518–24.CrossRefGoogle Scholar